FI90865B - Förfarande för framställning av farmaceutiskt användbara isokinolinderivat - Google Patents
Förfarande för framställning av farmaceutiskt användbara isokinolinderivat Download PDFInfo
- Publication number
- FI90865B FI90865B FI890072A FI890072A FI90865B FI 90865 B FI90865 B FI 90865B FI 890072 A FI890072 A FI 890072A FI 890072 A FI890072 A FI 890072A FI 90865 B FI90865 B FI 90865B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- hydrogen
- compound
- alkoxy
- acid addition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Claims (3)
1. Förfarande för framställning av en farma-ceutiskt användbar förening enligt formel I, R1 r2 io | I (I) 15 > 20 väri Rx Mr väte eller C14alkyl; Rj Mr väte och R3 Mr väte eller C14alkyl, eller R2 och R3 tillsammans bildar en med en prickad linje 25 visad tilläggsbindning; R4 är väte, C^alkyl eller fenyl; Rs är metoxi eller etoxi; R6 är väte, hydroxi, C14alkoxi, hydroxi(C24alkoxi) eller (Cj^alkoxi) - (C2_4alkoxi);
30 R7 och Ra oberoende av varandra är C^alkoxi eller (C3_ 4alkoxi)-(C2.4alkoxi); och R9 är väte eller halogen; eller för framställning av en dylik förenings syraadditionssalt, känneteck-n a t därav, att 35 a) pä en förening enligt formel II, 28 Rl R2' R6,v^>xyx/3R
5 TTT" n» 0 (ID ,A, R9 15 väri Rj' är väte och R3’ är väte eller C^alkyl; R5' och R6’ är de samma som i samband med forme 1 I, pA det villkor, att möjliga hydroxigrupper är i skyddad form; och Rx, R4, R7, Re och R9 är desamma som i formel I, 20 utförs en dehydrerande cyklisation, och vid behov, av-lägsnas skyddsgrupperna frin substituenterna Rs' och Rfi' för framställning av motsvarande förening enligt formel 1/ väri R2 är väte och R3 är väte eller C14alkyl; eller b) en förening enligt formel I, väri R2 och R} bida är 25 väte, dehydreras för framställning av motsvarande förening enligt formel I, väri R2 och R3 tillsammans bil-dar en tilläggsbindning; och den erhallna föreningen enligt formel I tas tillva-ra i fri form eller i form av ett syraadditionssalt. 30 2. Förfarande enligt patentkrav 1 för frams tällning av en förening enligt formel I eller dess syraadditionssalt, kännetecknat därav, att R3 - Rfl är definierade enligt patentkrav 1 och R9 är väte. 35 3. Förfarande enligt patentkrav 1 för frams tällning av 3-metyl-6,7-dimetoxi-l-[3,5-di(metoxieto-xi)-fenyl]-isokinolin eller dess syraadditionssalt. li
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888800397A GB8800397D0 (en) | 1988-01-08 | 1988-01-08 | Improvements in/relating to organic compounds |
| GB8800397 | 1988-01-08 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI890072A0 FI890072A0 (sv) | 1989-01-06 |
| FI890072A FI890072A (sv) | 1989-07-09 |
| FI90865B true FI90865B (sv) | 1993-12-31 |
| FI90865C FI90865C (sv) | 1994-04-11 |
Family
ID=10629678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI890072A FI90865C (sv) | 1988-01-08 | 1989-01-06 | Förfarande för framställning av farmaceutiskt användbara isokinolinderivat |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US4980359A (sv) |
| JP (1) | JPH0649686B2 (sv) |
| KR (1) | KR0142686B1 (sv) |
| AT (1) | AT394365B (sv) |
| AU (1) | AU622429B2 (sv) |
| BE (1) | BE1002730A3 (sv) |
| CA (1) | CA1332944C (sv) |
| CH (1) | CH678727A5 (sv) |
| DE (1) | DE3900233C2 (sv) |
| DK (1) | DK5789A (sv) |
| ES (1) | ES2010071A6 (sv) |
| FI (1) | FI90865C (sv) |
| FR (1) | FR2625743B1 (sv) |
| GB (2) | GB8800397D0 (sv) |
| GR (1) | GR1002750B (sv) |
| HU (1) | HU205083B (sv) |
| IE (1) | IE61914B1 (sv) |
| IL (1) | IL88899A (sv) |
| IT (1) | IT1229523B (sv) |
| LU (1) | LU87423A1 (sv) |
| MY (1) | MY103963A (sv) |
| NL (1) | NL8900029A (sv) |
| NZ (1) | NZ227561A (sv) |
| PH (1) | PH25640A (sv) |
| PL (1) | PL156099B1 (sv) |
| PT (1) | PT89405B (sv) |
| SE (1) | SE501548C2 (sv) |
| ZA (1) | ZA89133B (sv) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2723674A (en) * | 1951-11-28 | 1955-11-15 | Charles E Harris | Telephone cableman's tent |
| US3007541A (en) * | 1959-02-24 | 1961-11-07 | Jr John B Mast | Temporary covering and support structure therefor |
| GB8807922D0 (en) * | 1988-04-05 | 1988-05-05 | Fujisawa Pharmaceutical Co | Isoquinoline compound & process for preparation thereof |
| US4956371A (en) * | 1989-09-19 | 1990-09-11 | Euroceltique, S.A. | Substituted isoquinolines and methods of using same |
| GB8921304D0 (en) * | 1989-09-20 | 1989-11-08 | Wyeth John & Brother Ltd | New method of treatment and heterocyclic compounds used therein |
| GB9027055D0 (en) * | 1990-12-13 | 1991-02-06 | Sandoz Ltd | Organic compounds |
| BR9107169A (pt) * | 1990-12-17 | 1993-11-16 | Shell Int Research | Derivados de isoquinolina fungicidas |
| CA2093577C (en) * | 1992-05-07 | 2006-01-03 | Michael Klaus | Alkyl or alkoxy substituted s-heterocyclic retinoids |
| US5350423A (en) * | 1992-09-23 | 1994-09-27 | Burlington Industries Inc. | Fabric finishing procedure |
| GB9322828D0 (en) * | 1993-11-05 | 1993-12-22 | Sandoz Ltd | Organic compounds |
| CZ297045B6 (cs) * | 1994-12-23 | 2006-08-16 | Smithkline Beecham Corporation | Hlodavcí neutralizacní monoklonální protilátka, zpusob pro její produkci, kompozice s jejím obsahema pouzití, hybridom a jím produkovaná protilátka,fab fragment, komplementaritu urcující region, molekula nukleové kyseliny a její sekvence, plasmid a |
| US7399837B2 (en) * | 1995-12-22 | 2008-07-15 | Smithkline Beecham Corporation | Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| US5783184A (en) * | 1994-12-23 | 1998-07-21 | Smithkline Beecham Corporation | Method for treatment and diagnosis of IL-5 mediated disorders |
| US5693323A (en) * | 1994-12-23 | 1997-12-02 | Smithkline Beecham Corporation | Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| GB9622386D0 (en) * | 1996-10-28 | 1997-01-08 | Sandoz Ltd | Organic compounds |
| IT1296985B1 (it) * | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati benzazinici inibitori della fosfodiesterasi 4 |
| US6534518B1 (en) | 1999-01-15 | 2003-03-18 | Altana Pharma Ag | Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity |
| JP5038568B2 (ja) | 1999-08-21 | 2012-10-03 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 協力剤の組合せ物 |
| BRPI0409229A (pt) | 2003-04-01 | 2006-03-28 | Applied Research Systems | inibidores das fosfodiesterases na infertilidade |
| ES2492943T3 (es) * | 2007-04-30 | 2014-09-10 | Glaxosmithkline Llc | Procedimientos de administración de anticuerpos anti-IL5 |
| BRPI0910854A2 (pt) * | 2008-03-28 | 2015-10-06 | Glaxosmithkline Llc | métodos de tratamento |
| BRPI0920246A2 (pt) | 2008-10-17 | 2017-06-27 | Winconsin Alumni Res Foundation | método de preparação de alfa-beta peptídios biologicamente ativos. |
| WO2018226339A1 (en) | 2017-06-06 | 2018-12-13 | Glaxosmithkline Llc | Biopharmaceutical compositions and methods for pediatric patients |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB645139A (en) * | 1946-10-22 | 1950-10-25 | Servita Gyogyszeryar Es Vegyip | Improved process for the production of isoquinoline derivatives |
| DE1184344B (de) * | 1962-06-16 | 1964-12-31 | Orgamol Sa | Verfahren zur Herstellung von Isochinolinderivaten |
| US3878215A (en) * | 1971-12-01 | 1975-04-15 | Sandoz Ag | 2-Alkyl-3-substituted-4-aryl isoquinolines |
| DE2401453A1 (de) * | 1973-01-16 | 1974-07-18 | John James Voorhees | Pharmazeutische zusammensetzung zur behandlung von hautproliferationserkrankungen |
| US4018927A (en) * | 1973-12-17 | 1977-04-19 | The Regents Of The University Of Michigan | Treatment of proliferating skin diseases with papaverine alkaloids |
| SE7500859L (sv) * | 1974-02-05 | 1975-08-06 | Sandoz Ag | |
| DE2811361A1 (de) * | 1978-03-16 | 1979-09-27 | Hoechst Ag | Neue isochinolinaldehyde und verfahren zu ihrer herstellung |
| DE3244594A1 (de) * | 1982-12-02 | 1984-06-07 | Hoechst Ag, 6230 Frankfurt | 1-phenylisochinolinderivate und verfahren zu ihrer herstellung, diese verbindung enthaltende pharmazeutische praeparate und deren anwendung |
| HU196758B (en) * | 1986-05-21 | 1989-01-30 | Gyogyszerkutato Intezet | Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them |
| CA1330560C (en) * | 1986-05-21 | 1994-07-05 | Maurits E. A. Vandewalle | Di- and tetrahydroisoquinoline derivatives |
-
1988
- 1988-01-08 GB GB888800397A patent/GB8800397D0/en active Pending
-
1989
- 1989-01-03 HU HU8911A patent/HU205083B/hu not_active IP Right Cessation
- 1989-01-04 GB GB8900102A patent/GB2213482B/en not_active Expired - Lifetime
- 1989-01-04 IT IT8947504A patent/IT1229523B/it active
- 1989-01-05 DE DE3900233A patent/DE3900233C2/de not_active Expired - Fee Related
- 1989-01-05 ES ES8900053A patent/ES2010071A6/es not_active Expired
- 1989-01-05 CA CA000587599A patent/CA1332944C/en not_active Expired - Fee Related
- 1989-01-05 SE SE8900039A patent/SE501548C2/sv unknown
- 1989-01-06 LU LU87423A patent/LU87423A1/fr unknown
- 1989-01-06 FR FR898900128A patent/FR2625743B1/fr not_active Expired - Lifetime
- 1989-01-06 PT PT89405A patent/PT89405B/pt not_active IP Right Cessation
- 1989-01-06 DK DK005789A patent/DK5789A/da not_active Application Discontinuation
- 1989-01-06 IE IE3789A patent/IE61914B1/en not_active IP Right Cessation
- 1989-01-06 MY MYPI89000013A patent/MY103963A/en unknown
- 1989-01-06 BE BE8900018A patent/BE1002730A3/fr not_active IP Right Cessation
- 1989-01-06 NL NL8900029A patent/NL8900029A/nl not_active Application Discontinuation
- 1989-01-06 IL IL8889989A patent/IL88899A/en not_active IP Right Cessation
- 1989-01-06 PH PH38011A patent/PH25640A/en unknown
- 1989-01-06 FI FI890072A patent/FI90865C/sv not_active IP Right Cessation
- 1989-01-06 AU AU27795/89A patent/AU622429B2/en not_active Ceased
- 1989-01-06 ZA ZA89133A patent/ZA89133B/xx unknown
- 1989-01-06 NZ NZ227561A patent/NZ227561A/xx unknown
- 1989-01-06 JP JP1001898A patent/JPH0649686B2/ja not_active Expired - Lifetime
- 1989-01-06 PL PL1989277092A patent/PL156099B1/pl unknown
- 1989-01-07 KR KR1019890000151A patent/KR0142686B1/ko not_active IP Right Cessation
- 1989-01-09 AT AT0003589A patent/AT394365B/de not_active IP Right Cessation
- 1989-01-09 CH CH59/89A patent/CH678727A5/de not_active IP Right Cessation
- 1989-01-09 GR GR890100008A patent/GR1002750B/el unknown
-
1990
- 1990-04-10 US US07/507,702 patent/US4980359A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI90865B (sv) | Förfarande för framställning av farmaceutiskt användbara isokinolinderivat | |
| DK169337B1 (da) | Xanthinforbindelser, farmaceutisk præparat indeholdende disse, xanthinforbindelser til anvendelse som et farmaceutisk middel samt fremgangsmåde til fremstilling af forbindelserne | |
| US5614530A (en) | Substituted N-arylmethyl and heterocyclmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof | |
| KR101876792B1 (ko) | 호흡기 세포융합 바이러스 항바이러스제로서의 이미다조피리딘 | |
| SU1364238A3 (ru) | Способ получени производных пиримидо @ 4,5- @ хинолина или их оптически активных изомеров,или их фармацевтически приемлемых аддитивных солей кислоты | |
| GB1596476A (en) | Pyridopyrimidines | |
| FI90978C (sv) | Förfarande för framställning av terapeutiskt aktiva N-(pyridyl)-1H-indol-1-aminer | |
| CZ281669B6 (cs) | Nové dihydroisochinolinové deriváty | |
| KR20200101470A (ko) | 소마토스타틴 조절제의 제조 방법 | |
| CZ348995A3 (en) | 3-phenylisoquinolin-1(2h)-one derivatives, process of their preparation, medicament and pharmaceutical composition containing such derivatives | |
| NZ225430A (en) | N-aminobutyl-n-phenyl arylamides and pharmaceutical compositions | |
| EP0874849B1 (en) | 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives | |
| JPH03120254A (ja) | 薬学的活性を有する置換カルボキシテトラヒドロイソキノリンおよびその誘導体 | |
| US5968949A (en) | Substituted hydroisoquinoline derivatives and their use as pharmaceuticals | |
| NZ270371A (en) | 3-phenylsulphonyl-3,7-diazabicyclo[3.3.1]nonane derivatives; pharmaceutical compositions | |
| IE903616A1 (en) | Neuroprotectant Agents | |
| IE48278B1 (en) | Pyrido(1,2-a)pyrimidones | |
| DK171299B1 (da) | 4-Amino-6,7-dimethoxy-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)quinolin-forbindelser, farmaceutiske præparater indeholdende disse og deres anvendelse til fremstilling af antiarytmiske lægemidler | |
| KR880001430B1 (ko) | 옥타하이드로-옥사졸로[4,5-g]퀴놀린 유도체 | |
| WO1998001449A1 (en) | Novel compounds | |
| EP0767787B1 (en) | (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants | |
| US6008226A (en) | Substituted N-arylmethyl and heterocylylmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof | |
| FI87350B (fi) | Foerfarande foer framstaellning av antiarrytmiska medel samt mellanprodukter foer dessa medel. | |
| NZ256195A (en) | 2-substituted adenosine derivatives and pharmaceutical compositions | |
| EP0466933A1 (en) | Bicyclolactam derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| PC | Transfer of assignment of patent |
Owner name: NOVARTIS AG |
|
| MM | Patent lapsed |
Owner name: NOVARTIS AG |